· Daily · Newsletters
Resonance network: Quantum InsiderSpace Insider
Insider Brief Iambic Therapeutics, previously known as Entos, successfully closed an oversubscribed $100 million Series B financing round, co-led by Ascenta Capital and Abingworth. The funding also saw participation from new investors including NVIDIA
The daily briefing on LinkedIn. Free, one tap to follow.
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.